Marijuana Inhalers 101
Bethan Jenkins
July 25th, 2017
Policy
Cannabis contains more than 500 chemicals, with the most well-known chemical being phytocannabinoid tetrahydrocannabinol (THC). It is this active ingredient that gives cannabis users the “stoned” effect. Upon reacting with the brain, THC compounds engage with the brain’s Cannabinoid receptors. (Yep, we’ve all got them, didn’t you know?)
The green plant has been linked to higher IQ’s, decreased pain, better mood – the list goes on. In fact, man started using marijuana as a psychoactive substance thousands of years ago and the really exciting part is that as cannabis is gaining widespread acceptance around the States, the options for users are blossoming!
Spliffs, blunts and bongs aside, it seems that marijuana inhalers are taking the cannabis community by storm in particular. So, what is a marijuana inhaler and how does using one amplify the effects of THC on the mind and body? Let’s find out.
Vaporizing Marijuana Using an Inhaler
Remember when we spoke about TEVA’s cannabis inhaler in the past? Well, this tech product was a game-changer for marijuana consumption, much like the Vapen Clear was. Vapen’s product was the first ever pressurized metered dose inhaler (pMDI) to be introduced to the world. Since this time, various devices have been welcomed into the weed market.
Specially created to deliver high-quality marijuana concentrates and extracts, marijuana inhalers are usually pocket-sized devices that provide the user with a selective dose of Cannabinoids. The “medicine” is blasted directly into the lungs scent-free. You would be forgiven for thinking that some weed inhalers are the same as bronchodilator inhalers used by asthma sufferers. Truth is, they are very similar in the sense that drugs can be delivered to the user in metered doses.
Is vaporizing a safe way to consume cannabis?
To answer the above question, yes. Although the idea of consuming cannabis might have you fretting about the potential health problems (particularly for your lungs), this is what makes vaping such a refreshing alternative to smoking. Vaporizing cannabis still provides the typical effects, minus the damage caused by smoke inhalation. Marijuana inhaler devices require the user to breathe in vapor, which is a type of steam, rather than a cloud of toxic smoke.
Raw cannabis is placed in the vaporizer, which could be either a desktop plug-in device or a handheld pen. Instead of being heated to combustion point, the cannabis or cannabis oil is accurately heated into vapor form. This results in lower temperatures, less carbon monoxide intake and a reduction in the level of toxic hydrocarbons being inhaled.
Using the Mystabis for Medicinal Value
Now that you’re well-informed about using marijuana inhalers for your puffing pleasure, you are probably wondering which product is worth spending money on. While there are myriad brands to consider, such as V2, MigVapor and Grenco Science, the Mystabis is currently claiming the spotlight. Offering “polite discretion” for its users, the Mystabis is a pressurized metered dose inhaler pMDI.
Created for medical marijuana users, Mystabis is a product inspired by a son’s desire to ease his cancer-stricken father’s pain. Crafted with pharmaceutical grade materials, the cannabis inhaler is loaded with natural marijuana extracts. A coarse puff of aerosol is sprayed into the mouth and when exhaled, only five percent of the cannabis leaves the lungs, thus allowing for sufficient medication.
The Mystabis Inhaler functions as follows:
- Medical grade HFA-134a liquid propellant is transported through the nozzle.
- The user’s lungs are filled with cannabis in the form of a fine mist.
- Marijuana medicine is deposited in the central area of the lungs and throat.
- After five minutes, the user feels relaxed and less vulnerable to any pain or discomfort they were feeling previously.
Although this product is approved for use by medical marijuana users, anyone with a recommendation from their doctor to use medical cannabis should still consult with their healthcare provider, prior to using Mystabis.
Reasons to Swap Weed Smoking for Weed Vaping
You are likely to get a lot more out of your marijuana when you inhale it with a vaping device, rather than packing it into a joint. Based on a study conducted by MAPS and NORML, a normal joint only converts 25 percent of the THC (if that), while a marijuana inhaler delivers as much as 46 percent of the THC to a user in water vapor form.
Here are some additional reasons to replace the smokes with a shiny marijuana inhaler:
- Gain the freedom to try different cannabis strains with a vaping device
- Safeguard your health in the long-term
- Attract less attention when you take a hit
- Treat your taste buds to new flavors
- Get easy access to new products, upgrades and accessories online/at vape stores.
To learn more about new cannabis medical devices and other news, sign-up for our free newsletter using the form to the right.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Bethan Jenkins
Bethan is a full-time wanderluster, traveler, and digital nomad with 7 years of experience in the freelance writing world. She has mastered the art of beating jet lag and using hammocks as an office for content curation.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Flora is building a connected, design-led collective, of plant-based wellness and lifestyle brands, that delivers the most compelling customer experiences in the world, one community at a time.
Cannabix Technologies Inc. is a leader in marijuana breathalyzer development for law enforcement and the workplace.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
